Cargando…

Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol

BACKGROUND: Liraglutide is an injectable therapy to treat type 2 diabetes (T2DM), belonging to the glucagon-like peptide-1 receptor agonist class of drugs. The Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial established that liraglutide demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinton, William, Feher, Michael, Munro, Neil, de Lusignan, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984905/ https://www.ncbi.nlm.nih.gov/pubmed/29605893 http://dx.doi.org/10.1007/s13300-018-0390-8

Ejemplares similares

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol
por: Hinton, William, et al.
Publicado: (2019)

Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?
por: Hinton, William, et al.
Publicado: (2020)

Real‐world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice network
por: Hinton, William, et al.
Publicado: (2019)

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)
por: Feher, Michael, et al.
Publicado: (2022)

Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol)
por: de Lusignan, Simon, et al.
Publicado: (2019)

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol)
por: McGovern, Andrew, et al.
Publicado: (2017)

Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality
por: Feher, Michael, et al.
Publicado: (2021)

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use
por: McGovern, Andrew, et al.
Publicado: (2017)

Improving the Management of Atrial Fibrillation in General Practice: Protocol for a Mixed Methods Study
por: de Lusignan, Simon, et al.
Publicado: (2020)

Sodium–glucose co‐transporter‐2 inhibitor cardiovascular outcome trials and generalizability to English primary care
por: Hinton, W., et al.
Publicado: (2020)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
por: McGovern, Andrew, et al.
Publicado: (2016)

Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis
por: Feher, M., et al.
Publicado: (2019)

Context effects on object recognition in real-world environments: A study protocol
por: Nicholls, Victoria I., et al.
Publicado: (2023)

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial
por: Whicher, Clare Alexandra, et al.
Publicado: (2019)

Atrial fibrillation dashboard evaluation using the think aloud protocol
por: de Lusignan, Simon, et al.
Publicado: (2020)

Liraglutide and Glycaemic Outcomes in the LEADER Trial
por: Zinman, Bernard, et al.
Publicado: (2018)

Real-World Outcomes of Systemic Therapy in Japanese Patients with Cancer (Tokushukai REAl-World Data Project: TREAD): Study Protocol for a Nationwide Cohort Study
por: Shimoyama, Rai, et al.
Publicado: (2022)

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis
por: Hinton, William, et al.
Publicado: (2021)

Implementing nudges for suicide prevention in real-world environments: project INSPIRE study protocol
por: Davis, Molly, et al.
Publicado: (2020)

Hepatitis A Vaccination Coverage Among People With Chronic Liver Disease in England (HEALD): Protocol for a Retrospective Cohort Study
por: Meza-Torres, Bernardo, et al.
Publicado: (2023)

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
por: Femminella, Grazia Daniela, et al.
Publicado: (2019)

The Effect of the COVID-19 Pandemic on Glycemic Monitoring and Other Processes of Care for Type 2 Diabetes: Protocol for a Retrospective Cohort Study
por: Mathew, Mekha, et al.
Publicado: (2022)

Using Palliative Leaders in Facilities to Transform Care for People with Alzheimer’s Disease (UPLIFT-AD): protocol of a palliative care clinical trial in nursing homes
por: Unroe, Kathleen T., et al.
Publicado: (2023)

A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C
por: Ramsay, Jessica, et al.
Publicado: (2020)

Implementation of evidence-based parenting programs under real-world conditions: Protocol for a scoping review
por: Pinto, Rita, et al.
Publicado: (2021)

Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial
por: Zawertailo, Laurie, et al.
Publicado: (2018)

A small-scale, exploratory real-world study of nab-paclitaxel combined with oxaliplatin and tegafur in the perioperative treatment of advanced gastric cancer: a study protocol for a real-world clinical trial
por: Zheng, Jiyang, et al.
Publicado: (2023)

Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
por: Kalra, Sanjay
Publicado: (2016)

The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma
por: Woodcock, Ashley, et al.
Publicado: (2015)

Strengthening primary health care teams with palliative care leaders: protocol for a cluster randomized clinical trial
por: Llobera, Joan, et al.
Publicado: (2017)

Identifying student opinion leaders to lead e-cigarette interventions: protocol for a randomized controlled pragmatic trial
por: Chu, Kar-Hai, et al.
Publicado: (2021)

Improving access to community-based pulmonary rehabilitation: 3R protocol for real-world settings with cost-benefit analysis
por: Marques, Alda, et al.
Publicado: (2019)

Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet
por: Lv, Junchao, et al.
Publicado: (2022)

Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol
por: Mikolaizak, A. Stefanie, et al.
Publicado: (2022)

Effectiveness and safety of oral anticoagulant therapy in a real-world cohort with atrial fibrillation: The SIESTA-A study protocol
por: Montero-Balosa, M. C., et al.
Publicado: (2023)

A study protocol to evaluate the implementation and effectiveness of the Clinical Nurse Leader Care Model in improving quality and safety outcomes
por: Bender, Miriam, et al.
Publicado: (2021)

Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study
por: Lyu, Shaohua, et al.
Publicado: (2022)

Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
por: Norman, Jane E, et al.
Publicado: (2012)

Functional antigen matching in corneal transplantation: matching for the HLA-A, -B and -DRB1 antigens (FANCY) – study protocol
por: Böhringer, Daniel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k1kvu7tum1hbckj5fo8cch49p7